Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9279 |
High Similarity |
NPD228 |
Approved |
0.9098 |
High Similarity |
NPD3027 |
Phase 3 |
0.8621 |
High Similarity |
NPD5283 |
Phase 1 |
0.8509 |
High Similarity |
NPD2684 |
Approved |
0.85 |
High Similarity |
NPD1357 |
Approved |
0.8455 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8438 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8438 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.8376 |
Intermediate Similarity |
NPD7843 |
Approved |
0.8319 |
Intermediate Similarity |
NPD7157 |
Approved |
0.8295 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8295 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8276 |
Intermediate Similarity |
NPD3021 |
Approved |
0.8276 |
Intermediate Similarity |
NPD3022 |
Approved |
0.8103 |
Intermediate Similarity |
NPD290 |
Approved |
0.8077 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7984 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7982 |
Intermediate Similarity |
NPD291 |
Approved |
0.7928 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7907 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7907 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7886 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7863 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7863 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7857 |
Intermediate Similarity |
NPD3705 |
Approved |
0.781 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7744 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7734 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7734 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7734 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7669 |
Intermediate Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.7656 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7634 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7612 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7591 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7559 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7559 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7559 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7557 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7554 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7554 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7554 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7554 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7544 |
Intermediate Similarity |
NPD2859 |
Approved |
0.7544 |
Intermediate Similarity |
NPD2860 |
Approved |
0.7536 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3020 |
Approved |
0.75 |
Intermediate Similarity |
NPD6653 |
Approved |
0.75 |
Intermediate Similarity |
NPD1358 |
Approved |
0.75 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD7526 |
Approved |
0.7483 |
Intermediate Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD52 |
Approved |
0.748 |
Intermediate Similarity |
NPD821 |
Approved |
0.7463 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7463 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7463 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7462 |
Intermediate Similarity |
NPD3685 |
Discontinued |
0.7456 |
Intermediate Similarity |
NPD2934 |
Approved |
0.7456 |
Intermediate Similarity |
NPD2933 |
Approved |
0.7456 |
Intermediate Similarity |
NPD1432 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7445 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7445 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7445 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7444 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7429 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7426 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7422 |
Intermediate Similarity |
NPD9384 |
Approved |
0.7422 |
Intermediate Similarity |
NPD9381 |
Approved |
0.7417 |
Intermediate Similarity |
NPD968 |
Approved |
0.7415 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7405 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7391 |
Intermediate Similarity |
NPD844 |
Approved |
0.7388 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7385 |
Intermediate Similarity |
NPD2231 |
Phase 2 |
0.7385 |
Intermediate Similarity |
NPD2235 |
Phase 2 |
0.7379 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7377 |
Intermediate Similarity |
NPD5451 |
Approved |
0.7377 |
Intermediate Similarity |
NPD556 |
Approved |
0.7376 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7365 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7364 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7348 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7344 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7339 |
Intermediate Similarity |
NPD9377 |
Approved |
0.7339 |
Intermediate Similarity |
NPD9379 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7328 |
Intermediate Similarity |
NPD6583 |
Phase 3 |
0.7328 |
Intermediate Similarity |
NPD6582 |
Phase 2 |
0.7328 |
Intermediate Similarity |
NPD9622 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7308 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD3691 |
Phase 2 |
0.7293 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD3690 |
Phase 2 |
0.7287 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7287 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7286 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7266 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7266 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7266 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7266 |
Intermediate Similarity |
NPD3091 |
Approved |
0.726 |
Intermediate Similarity |
NPD3687 |
Approved |
0.726 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7252 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7252 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7252 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7248 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.7231 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7227 |
Intermediate Similarity |
NPD846 |
Approved |
0.7227 |
Intermediate Similarity |
NPD940 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7226 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7218 |
Intermediate Similarity |
NPD1818 |
Approved |
0.7218 |
Intermediate Similarity |
NPD1820 |
Approved |
0.7218 |
Intermediate Similarity |
NPD1819 |
Approved |
0.7218 |
Intermediate Similarity |
NPD1817 |
Approved |
0.7206 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7206 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7197 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7197 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7194 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7194 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7193 |
Intermediate Similarity |
NPD9365 |
Approved |
0.7185 |
Intermediate Similarity |
NPD600 |
Approved |
0.7185 |
Intermediate Similarity |
NPD596 |
Approved |
0.7181 |
Intermediate Similarity |
NPD37 |
Approved |
0.7179 |
Intermediate Similarity |
NPD288 |
Approved |
0.7177 |
Intermediate Similarity |
NPD9280 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7164 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7164 |
Intermediate Similarity |
NPD9619 |
Approved |
0.7164 |
Intermediate Similarity |
NPD558 |
Phase 2 |
0.7164 |
Intermediate Similarity |
NPD9620 |
Approved |
0.7164 |
Intermediate Similarity |
NPD9621 |
Approved |
0.7163 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7163 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7161 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7153 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7153 |
Intermediate Similarity |
NPD839 |
Approved |
0.7153 |
Intermediate Similarity |
NPD840 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD289 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7133 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7132 |
Intermediate Similarity |
NPD3164 |
Approved |
0.7132 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD3165 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3166 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3179 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3167 |
Approved |
0.7132 |
Intermediate Similarity |
NPD3180 |
Approved |
0.7117 |
Intermediate Similarity |
NPD111 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7101 |
Intermediate Similarity |
NPD825 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7101 |
Intermediate Similarity |
NPD826 |
Approved |
0.7095 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7086 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7083 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7083 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.708 |
Intermediate Similarity |
NPD601 |
Approved |
0.708 |
Intermediate Similarity |
NPD598 |
Approved |
0.708 |
Intermediate Similarity |
NPD597 |
Approved |
0.7077 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7071 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7068 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7068
|
Intermediate Similarity |
NPD3676 |
Clinical (unspecified phase) |